Correlation Between Arco Platform and Kiniksa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Arco Platform and Kiniksa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arco Platform and Kiniksa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arco Platform and Kiniksa Pharmaceuticals, you can compare the effects of market volatilities on Arco Platform and Kiniksa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arco Platform with a short position of Kiniksa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arco Platform and Kiniksa Pharmaceuticals.
Diversification Opportunities for Arco Platform and Kiniksa Pharmaceuticals
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Arco and Kiniksa is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Arco Platform and Kiniksa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiniksa Pharmaceuticals and Arco Platform is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arco Platform are associated (or correlated) with Kiniksa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiniksa Pharmaceuticals has no effect on the direction of Arco Platform i.e., Arco Platform and Kiniksa Pharmaceuticals go up and down completely randomly.
Pair Corralation between Arco Platform and Kiniksa Pharmaceuticals
Given the investment horizon of 90 days Arco Platform is expected to generate 6.63 times less return on investment than Kiniksa Pharmaceuticals. But when comparing it to its historical volatility, Arco Platform is 1.33 times less risky than Kiniksa Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Kiniksa Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 1,534 in Kiniksa Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 646.00 from holding Kiniksa Pharmaceuticals or generate 42.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 31.72% |
| Values | Daily Returns |
Arco Platform vs. Kiniksa Pharmaceuticals
Performance |
| Timeline |
| Arco Platform |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Kiniksa Pharmaceuticals |
Arco Platform and Kiniksa Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arco Platform and Kiniksa Pharmaceuticals
The main advantage of trading using opposite Arco Platform and Kiniksa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arco Platform position performs unexpectedly, Kiniksa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiniksa Pharmaceuticals will offset losses from the drop in Kiniksa Pharmaceuticals' long position.| Arco Platform vs. Adtalem Global Education | Arco Platform vs. American Public Education | Arco Platform vs. Laureate Education | Arco Platform vs. Grand Canyon Education |
| Kiniksa Pharmaceuticals vs. Nuvalent | Kiniksa Pharmaceuticals vs. Ventyx Biosciences | Kiniksa Pharmaceuticals vs. Arcellx | Kiniksa Pharmaceuticals vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |